Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Endoscopic features aiding the diagnosis of gastric mucosa-associated lymphoid tissue lymphoma

  • Park, Byung Sam (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Lee, Si Hyung (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine)
  • Received : 2018.12.28
  • Accepted : 2019.02.18
  • Published : 2019.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

The incidence of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is increasing worldwide, but the diagnosis is difficult. Most patients are asymptomatic or complain of nonspecific gastrointestinal symptoms. As the endoscopic features of gastric MALT lymphoma are variable and nonspecific, the possibility of this condition may be overlooked during esophagogastroduodenoscopy, and it remain undiagnosed. Therefore, this condition needs to be considered when an abnormal mucosa is observed during this procedure. Biopsy performed during endoscopy is the primary diagnostic test, but false negative results are possible; large numbers of samples should be collected from both normal and abnormal mucosae. Endoscopic ultrasonography is useful to assess the depth of invasion and to predict the treatment response. After treatment, follow-up tests are required every 3 months until complete remission is achieved, and annually thereafter. Early diagnosis of gastric MALT lymphoma is difficult, and its diagnosis and follow-up require wide experience and competent endoscopic technique.

Keywords

References

  1. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-5. https://doi.org/10.1016/0140-6736(92)90280-G
  2. Papaxoinis G, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Pavlidis N, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma 2006;47:2140-6. https://doi.org/10.1080/10428190600709226
  3. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007;136:521-38. https://doi.org/10.1111/j.1365-2141.2006.06444.x
  4. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-18. https://doi.org/10.1182/blood.v89.11.3909
  5. Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer 2013;119:629-38. https://doi.org/10.1002/cncr.27773
  6. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6. https://doi.org/10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3
  7. Ruskone-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F, et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011;60:747-58. https://doi.org/10.1136/gut.2010.224949
  8. Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto Met al. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi144-8. https://doi.org/10.1093/annonc/mdt343
  9. Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010;8:105-10. https://doi.org/10.1016/j.cgh.2009.07.017
  10. Ono S, Kato M, Takagi K, Kodaira J, Kubota K, Matsuno Y, et al. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer. J Gastroenterol Hepatol 2010;25:804-9. https://doi.org/10.1111/j.1440-1746.2009.06204.x
  11. Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 2012;61:507-13. https://doi.org/10.1136/gutjnl-2011-300495
  12. Kelessis NG, Vassilopoulos PP, Tsamakidis KG, Bai MG, Avital S, Rosenthal RJ. Is gastroscopy still a valid diagnostic tool in detecting gastric MALT lymphomas? A dilemma beyond the eye. Mucosa-associated lymphoid tissue. Surg Endosc 2003;17:469-74. https://doi.org/10.1007/s00464-002-8544-0
  13. Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 2009;20:1086-93. https://doi.org/10.1093/annonc/mdn760
  14. Taal BG, den Hartog Jager FC, Tytgat GN. The endoscopic spectrum of primary non-Hodgkin's lymphoma of the stomach. Endoscopy 1987;19:190-2. https://doi.org/10.1055/s-2007-1018279
  15. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-9. https://doi.org/10.1182/blood.V96.2.410
  16. Lee SK, Lee YC, Chung JB, Chon CY, Moon YM, Kang JK, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol 2004;10:223-6. https://doi.org/10.3748/wjg.v10.i2.223
  17. Aoun JP, Moukarbel N, Khoury S. Endoscopic patterns of primary gastric MALT lymphoma. J Med Liban 1998;46:131-5.
  18. Yokoi T, Nakamura T, Nakamura S. Differential diagnosis of gastric MALT lymphomas. Stomach Intest 2001;36:13-20.
  19. Caletti G, Barbara L. Gastric lymphoma: difficult to diagnose, difficult to stage? Endoscopy 1993;25:528-30. https://doi.org/10.1055/s-2007-1010390
  20. Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut 1996;39:556-61. https://doi.org/10.1136/gut.39.4.556
  21. Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res 2016;4:15. https://doi.org/10.1186/s40364-016-0068-1
  22. Suekane H, Iida M, Kuwano Y, Kohrogi N, Yao T, Iwashita A, et al. Diagnosis of primary early gastric lymphoma. Usefulness of endoscopic mucosal resection for histologic evaluation. Cancer 1993;71:1207-13. https://doi.org/10.1002/1097-0142(19930215)71:4<1207::AID-CNCR2820710406>3.0.CO;2-O
  23. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7. https://doi.org/10.1016/0140-6736(93)91409-F
  24. Hummel M, Oeschger S, Barth TF, Loddenkemper C, Cogliatti SB, Marx A, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut 2006;55:782-7. https://doi.org/10.1136/gut.2005.080523
  25. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006;55:886-93. https://doi.org/10.1136/gut.2004.061663
  26. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39-40. https://doi.org/10.1016/S0140-6736(00)03571-6
  27. Zullo A, Hassan C, Andriani A, Cristofari F, Cardinale V, Spinelli GP, et al. Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol 2010;44:340-4. https://doi.org/10.1097/mcg.0b013e3181b4b1ab
  28. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6-30. https://doi.org/10.1136/gutjnl-2016-312288
  29. Hartman DJ, Owens SR. Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens? An institutional quality assurance review. Am J Clin Pathol 2012;137:255-60. https://doi.org/10.1309/AJCPD8FFBJ5LSLTE
  30. Wang XI, Zhang S, Abreo F, Thomas J. The role of routine immunohistochemistry for Helicobacter pylori in gastric biopsy. Ann Diagn Pathol 2010;14:256-9. https://doi.org/10.1016/j.anndiagpath.2010.05.002
  31. Nonaka K, Ishikawa K, Arai S, Nakao M, Shimizu M, Sakurai T, et al. A case of gastric mucosa-associated lymphoid tissue lymphoma in which magnified endoscopy with narrow band imaging was useful in the diagnosis. World J Gastrointest Endosc 2012;4:151-6. https://doi.org/10.4253/wjge.v4.i4.151
  32. Deng P, Min M, Ma CY, Liu Y. Linked color imaging technology for diagnosis of gastric mucosa-associated lymphoid tissue lymphoma. Chin Med J (Engl) 2017;130:2759-60. https://doi.org/10.4103/0366-6999.214137
  33. Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14-27.
  34. Palazzo L, Roseau G, Ruskone-Fourmestraux A, Rougier P, Chaussade S, Rambaud JC, et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy 1993;25:502-8. https://doi.org/10.1055/s-2007-1010385
  35. Mehra M, Agarwal B. Endoscopic diagnosis and staging of mucosa-associated lymphoid tissue lymphoma. Curr Opin Gastroenterol 2008;24:623-6. https://doi.org/10.1097/MOG.0b013e32830bf80f
  36. Levy M, Hammel P, Lamarque D, Marty O, Chaumette MT, Haioun C, et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997;46:328-33. https://doi.org/10.1016/S0016-5107(97)70120-2
  37. Queneau PE, Helg C, Brundler MA, Frossard JL, Spahr L, Girardet C, et al. Diagnosis of a gastric mucosa-associated lymphoid tissue lymphoma by endoscopic ultrasonography-guided biopsies in a patient with a parotid gland localization. Scand J Gastroenterol 2002;37:493-6. https://doi.org/10.1080/003655202317316150
  38. El-Zahabi LM, Jamali FR, El-Hajj II, Naja M, Salem Z, Shamseddine A, et al. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc 2007;65:89-96. https://doi.org/10.1016/j.gie.2006.05.009
  39. Sheu BS, Shiesh SC, Wang JT, Yang HB, Lin ST, Wu JJ. Clinical application of 20 MHz endosonography and anti-Helicobacter pylori immunoblots to predict regression of low-grade gastric MALToma by H. pylori eradication. Helicobacter 2003;8:36-45.
  40. Yeh HZ, Chen GH, Chang WD, Poon SK, Yang SS, Lien HC, et al. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. J Gastroenterol Hepatol 2003;18:162-7. https://doi.org/10.1046/j.1440-1746.2003.02938.x
  41. Janssen J. The impact of EUS in primary gastric lymphoma. Best Pract Res Clin Gastroenterol 2009;23:671-8. https://doi.org/10.1016/j.bpg.2009.05.008
  42. Choi YJ, Lee DH, Kim JY, Kwon JE, Kim JY, Jo HJ, et al. Low grade gastric mucosa-associated lymphoid tissue lymphoma: clinicopathological factors associated with helicobacter pylori eradication and tumor regression. Clin Endosc 2011;44:101-8. https://doi.org/10.5946/ce.2011.44.2.101
  43. Ryu KD, Kim GH, Park SO, Lee KJ, Moon JY, Jeon HK, et al. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience. Gut Liver 2014;8:408-14. https://doi.org/10.5009/gnl.2014.8.4.408
  44. Thieblemont C, Zucca E. Clinical aspects and therapy of gastrointestinal MALT lymphoma. Best Pract Res Clin Haematol 2017;30:109-17. https://doi.org/10.1016/j.beha.2017.01.002
  45. Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005;23:8018-24. https://doi.org/10.1200/JCO.2005.02.3903
  46. Urakami Y, Sano T, Begum S, Endo H, Kawamata H, Oki Y. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. J Gastroenterol Hepatol 2000;15:1113-9. https://doi.org/10.1046/j.1440-1746.2000.02317.x
  47. Ono S, Kato M, Ono Y, Nakagawa M, Shimizu Y, Asaka M. Magnified endoscopic images of gastric MALT lymphoma before and after treatment. Endoscopy 2007;39(Suppl 1):E328. https://doi.org/10.1055/s-2007-966826
  48. Ishihara R, Tatsuta M, Iishi H, Uedo N, Narahara H, Ishiguro S. Usefulness of endoscopic appearance for choosing a biopsy target site and determining complete remission of primary gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori infection. Am J Gastroenterol 2002;97:772-4. https://doi.org/10.1111/j.1572-0241.2002.05579.x
  49. Palmela C, Fonseca C, Faria R, Baptista RB, Ribeiro S, Ferreira AO. Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study. United European Gastroenterol J 2017;5:473-8. https://doi.org/10.1177/2050640616671643

Cited by

  1. Primary mucosal-associated lymphoid tissue extranodal marginal zone lymphoma of the bladder from an imaging perspective: A case report vol.9, pp.32, 2019, https://doi.org/10.12998/wjcc.v9.i32.10024